Pancreatic Cancer Screening Using the Enzeavour Assay in Japan
Recruiting
N/A
Interventional Study
Pancreatic Cancer
Pancreatic Neoplasms
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 20 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 10,000 (estimated)
- Sponsor
- Cosomil, Inc. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This nationwide, multicenter, prospective, single-arm interventional feasibility study evaluates the Enzeavour Pancreatic Cancer assay in routine health checkups and cancer screening in Japan. Approximately 10,000 asymptomatic adults will be enrolled. Participants with an Enzeavour Score above 0.369 will undergo diagnostic work-up as clinically indicated. The primary outcome is pancreatic cancer d…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Asymptomatic adults attending participating facilities for routine health checkups, organized cancer screening, or both
* Able to understand the study procedures and provide written informed consent before enrollment
Exclusion Criteria:
* Documented clinical history of pancr…
Contacts